Share Price and Basic Stock Data
Last Updated: January 23, 2026, 8:23 pm
| PEG Ratio | 0.70 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ashok Leyland Ltd, a key player in the Indian auto sector focusing on light commercial vehicles (LCVs) and heavy commercial vehicles (HCVs), reported a market capitalization of ₹1,07,139 Cr. As of the latest quarter ending September 2023, the company recorded sales of ₹11,429 Cr., marking a significant recovery from ₹9,600 Cr. in September 2022. This upward trend in revenue is reflective of the company’s robust performance as it capitalized on the growing demand in the commercial vehicle segment, with total sales for the fiscal year ending March 2025 anticipated to reach ₹48,535 Cr., up from ₹41,673 Cr. in March 2023. The company’s operating profit margin (OPM) improved to 19% in the latest financial year, showcasing efficient cost management. Additionally, the trailing twelve months (TTM) sales stood at ₹50,976 Cr., indicating a solid growth trajectory, underscoring the effective execution of its business strategy amidst a competitive market landscape.
Profitability and Efficiency Metrics
Ashok Leyland’s profitability metrics demonstrate significant improvement over the past years, with a reported net profit of ₹3,543 Cr. for the fiscal year ending March 2025, up from ₹1,359 Cr. in March 2023. The return on equity (ROE) stood at an impressive 28.8%, reflecting strong shareholder returns compared to typical sector ranges. The company’s interest coverage ratio (ICR) of 2.43x indicates a solid ability to meet interest obligations, suggesting financial stability. Moreover, the operating profit margin has shown consistent growth, rising from 12% in March 2023 to 19% in March 2025. However, the increasing trend in interest expenses, which reached ₹3,930 Cr. in March 2025, raises concerns about potential impacts on profitability if not managed effectively. The company’s cash conversion cycle (CCC) of -21 days indicates strong operational efficiency, allowing for quick conversion of sales into cash, which is a positive sign for liquidity management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Ashok Leyland reflects a mixed picture of strength and leverage. The company’s total borrowings increased to ₹54,513 Cr. as of September 2025, up from ₹31,161 Cr. in March 2023, resulting in a total debt-to-equity ratio of 4.06x, significantly higher than the typical sector average. This high leverage could pose risks in a rising interest rate environment. However, the company has also reported reserves of ₹11,996 Cr., indicating a strong equity base that can cushion against potential downturns. Furthermore, the return on capital employed (ROCE) stood at 14.3%, showing effective use of capital. The book value per share also improved to ₹41.66, supporting the company’s valuation metrics. Despite the high leverage, the company’s ability to generate consistent profits and maintain a healthy equity base provides some reassurance to investors regarding its financial health.
Shareholding Pattern and Investor Confidence
The shareholding structure of Ashok Leyland reveals a stable composition that reflects investor confidence. Promoters hold a substantial 51.51% stake, ensuring that the company remains under strong management oversight. Foreign institutional investors (FIIs) have increased their stake to 24.32%, indicating heightened interest from external investors, which can be seen as a vote of confidence in the company’s growth prospects. Domestic institutional investors (DIIs) hold 13.59%, while the public holds 10.51%. The total number of shareholders has risen to 14,50,991, reflecting growing retail participation. This diversification of ownership can enhance corporate governance and increase market visibility. However, the decline in DIIs from 21.16% in December 2022 to the current 13.59% could signal caution among domestic funds regarding market conditions or company performance, warranting close monitoring.
Outlook, Risks, and Final Insight
Ashok Leyland’s outlook appears promising, driven by strong sales growth and improving profitability metrics. However, challenges remain, particularly regarding its high debt levels in relation to equity, which could pose risks if market conditions deteriorate. The increasing interest expenses could further impact net profit margins if not managed efficiently. Additionally, fluctuations in raw material prices and supply chain disruptions could adversely affect operational efficiency. On the upside, continued demand in the commercial vehicle sector and strategic initiatives to enhance product offerings may provide robust growth opportunities. The company’s ability to navigate these risks while leveraging its operational strengths will be crucial in sustaining its growth momentum. Overall, Ashok Leyland is well-positioned to capitalize on growth trends, provided it maintains a careful balance between leveraging growth and managing financial risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Force Motors Ltd | 25,465 Cr. | 19,325 | 22,000/6,125 | 31.0 | 2,661 | 0.21 % | 30.0 % | 20.8 % | 10.0 |
| SML Mahindra Ltd (SML ISUZU Ltd) | 5,315 Cr. | 3,676 | 4,745/1,028 | 33.5 | 307 | 0.49 % | 27.1 % | 36.4 % | 10.0 |
| Olectra Greentech Ltd | 8,105 Cr. | 989 | 1,714/974 | 56.7 | 137 | 0.04 % | 20.5 % | 14.3 % | 4.00 |
| Tata Motors Ltd | 1,47,974 Cr. | 402 | 538/324 | 6.84 | 316 | 1.49 % | 20.0 % | 28.1 % | 2.00 |
| Ashok Leyland Ltd | 1,13,252 Cr. | 193 | 199/95.2 | 33.9 | 21.4 | 1.62 % | 14.3 % | 28.8 % | 1.00 |
| Industry Average | 60,022.20 Cr | 4,917.00 | 32.39 | 688.48 | 0.77% | 22.38% | 25.68% | 5.40 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,600 | 10,400 | 13,203 | 9,691 | 11,429 | 11,093 | 13,542 | 10,724 | 11,148 | 11,995 | 14,696 | 11,709 | 12,577 |
| Expenses | 8,580 | 9,055 | 11,245 | 8,183 | 9,559 | 9,131 | 10,975 | 8,856 | 9,108 | 9,659 | 11,705 | 9,535 | 10,136 |
| Operating Profit | 1,020 | 1,344 | 1,958 | 1,509 | 1,870 | 1,961 | 2,567 | 1,868 | 2,040 | 2,336 | 2,991 | 2,173 | 2,441 |
| OPM % | 11% | 13% | 15% | 16% | 16% | 18% | 19% | 17% | 18% | 19% | 20% | 19% | 19% |
| Other Income | 32 | 36 | 97 | 53 | -1 | 46 | 10 | 36 | 245 | 75 | 22 | 103 | 103 |
| Interest | 499 | 545 | 582 | 655 | 715 | 783 | 829 | 904 | 962 | 1,011 | 1,053 | 1,112 | 1,152 |
| Depreciation | 209 | 220 | 259 | 227 | 227 | 241 | 233 | 235 | 244 | 268 | 340 | 273 | 268 |
| Profit before tax | 344 | 615 | 1,214 | 679 | 927 | 984 | 1,516 | 765 | 1,078 | 1,132 | 1,621 | 891 | 1,124 |
| Tax % | 46% | 43% | 34% | 14% | 39% | 38% | 38% | 28% | 29% | 28% | 23% | 26% | 27% |
| Net Profit | 186 | 351 | 803 | 584 | 569 | 609 | 934 | 551 | 767 | 820 | 1,246 | 658 | 820 |
| EPS in Rs | 0.28 | 0.54 | 1.28 | 0.93 | 0.90 | 0.95 | 1.45 | 0.87 | 1.20 | 1.30 | 1.92 | 1.04 | 1.29 |
Last Updated: January 13, 2026, 1:46 am
Below is a detailed analysis of the quarterly data for Ashok Leyland Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 12,577.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,709.00 Cr. (Jun 2025) to 12,577.00 Cr., marking an increase of 868.00 Cr..
- For Expenses, as of Sep 2025, the value is 10,136.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,535.00 Cr. (Jun 2025) to 10,136.00 Cr., marking an increase of 601.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 2,441.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,173.00 Cr. (Jun 2025) to 2,441.00 Cr., marking an increase of 268.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00%.
- For Other Income, as of Sep 2025, the value is 103.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 103.00 Cr..
- For Interest, as of Sep 2025, the value is 1,152.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,112.00 Cr. (Jun 2025) to 1,152.00 Cr., marking an increase of 40.00 Cr..
- For Depreciation, as of Sep 2025, the value is 268.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 273.00 Cr. (Jun 2025) to 268.00 Cr., marking a decrease of 5.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1,124.00 Cr.. The value appears strong and on an upward trend. It has increased from 891.00 Cr. (Jun 2025) to 1,124.00 Cr., marking an increase of 233.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 820.00 Cr.. The value appears strong and on an upward trend. It has increased from 658.00 Cr. (Jun 2025) to 820.00 Cr., marking an increase of 162.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.29. The value appears strong and on an upward trend. It has increased from 1.04 (Jun 2025) to 1.29, marking an increase of 0.25.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,859 | 15,708 | 21,260 | 22,871 | 29,636 | 33,197 | 21,951 | 19,454 | 26,237 | 41,673 | 45,703 | 48,535 | 50,976 |
| Expenses | 11,437 | 14,191 | 18,281 | 19,826 | 25,387 | 28,287 | 18,718 | 16,992 | 23,472 | 36,580 | 37,848 | 39,327 | 41,035 |
| Operating Profit | 422 | 1,517 | 2,979 | 3,045 | 4,248 | 4,910 | 3,233 | 2,462 | 2,765 | 5,093 | 7,856 | 9,208 | 9,942 |
| OPM % | 4% | 10% | 14% | 13% | 14% | 15% | 15% | 13% | 11% | 12% | 17% | 19% | 20% |
| Other Income | 613 | -106 | -321 | 406 | 190 | 139 | 57 | 207 | -230 | 166 | 160 | 405 | 304 |
| Interest | 805 | 872 | 925 | 1,049 | 1,227 | 1,502 | 1,802 | 1,901 | 1,869 | 2,094 | 2,982 | 3,930 | 4,328 |
| Depreciation | 530 | 580 | 524 | 573 | 646 | 676 | 750 | 836 | 866 | 900 | 927 | 1,087 | 1,149 |
| Profit before tax | -300 | -42 | 1,209 | 1,829 | 2,565 | 2,872 | 739 | -67 | -200 | 2,265 | 4,106 | 4,596 | 4,768 |
| Tax % | -23% | 415% | 41% | 11% | 29% | 24% | 38% | 4% | 43% | 40% | 34% | 26% | |
| Net Profit | -222 | -205 | 712 | 1,633 | 1,814 | 2,195 | 460 | -70 | -285 | 1,359 | 2,696 | 3,383 | 3,543 |
| EPS in Rs | -0.31 | 0.24 | 1.20 | 2.79 | 3.01 | 3.54 | 0.57 | -0.28 | -0.61 | 2.11 | 4.23 | 5.29 | 5.55 |
| Dividend Payout % | 0% | 96% | 40% | 28% | 40% | 44% | 44% | -107% | -82% | 62% | 59% | 59% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.66% | 447.32% | 129.35% | 11.08% | 21.00% | -79.04% | -115.22% | -307.14% | 576.84% | 98.38% | 25.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | 439.66% | -317.96% | -118.27% | 9.92% | -100.05% | -36.17% | -191.93% | 883.98% | -478.46% | -72.90% |
Ashok Leyland Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 54% |
| 3 Years: | 284% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 30% |
| 3 Years: | 16% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 15% |
| 3 Years: | 25% |
| Last Year: | 29% |
Last Updated: September 4, 2025, 11:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:58 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 266 | 285 | 285 | 285 | 293 | 294 | 294 | 294 | 294 | 294 | 294 | 294 | 587 |
| Reserves | 3,723 | 4,227 | 4,979 | 6,108 | 7,128 | 8,452 | 7,495 | 7,568 | 7,010 | 8,258 | 8,711 | 11,938 | 11,996 |
| Borrowings | 8,500 | 9,070 | 11,054 | 13,168 | 15,791 | 19,168 | 22,417 | 24,077 | 24,145 | 31,161 | 40,802 | 49,962 | 54,513 |
| Other Liabilities | 5,035 | 6,011 | 5,806 | 7,048 | 10,171 | 11,212 | 7,924 | 10,119 | 12,125 | 14,984 | 17,788 | 19,352 | 18,214 |
| Total Liabilities | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 | 85,310 |
| Fixed Assets | 7,573 | 6,529 | 5,890 | 6,591 | 6,596 | 6,695 | 8,031 | 8,484 | 7,895 | 8,146 | 8,157 | 8,837 | 9,499 |
| CWIP | 297 | 216 | 87 | 244 | 439 | 678 | 574 | 336 | 240 | 268 | 415 | 577 | 1,042 |
| Investments | 1,165 | 1,499 | 1,031 | 1,933 | 4,383 | 1,492 | 960 | 1,096 | 2,652 | 4,852 | 2,329 | 6,610 | 5,547 |
| Other Assets | 8,491 | 11,348 | 15,115 | 17,841 | 21,965 | 30,261 | 28,565 | 32,143 | 32,787 | 41,430 | 56,695 | 65,523 | 69,223 |
| Total Assets | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 | 85,310 |
Below is a detailed analysis of the balance sheet data for Ashok Leyland Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 587.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 293.00 Cr..
- For Reserves, as of Sep 2025, the value is 11,996.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,938.00 Cr. (Mar 2025) to 11,996.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2025, the value is 54,513.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 49,962.00 Cr. (Mar 2025) to 54,513.00 Cr., marking an increase of 4,551.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 18,214.00 Cr.. The value appears to be improving (decreasing). It has decreased from 19,352.00 Cr. (Mar 2025) to 18,214.00 Cr., marking a decrease of 1,138.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 85,310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81,546.00 Cr. (Mar 2025) to 85,310.00 Cr., marking an increase of 3,764.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 9,499.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,837.00 Cr. (Mar 2025) to 9,499.00 Cr., marking an increase of 662.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 577.00 Cr. (Mar 2025) to 1,042.00 Cr., marking an increase of 465.00 Cr..
- For Investments, as of Sep 2025, the value is 5,547.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,610.00 Cr. (Mar 2025) to 5,547.00 Cr., marking a decrease of 1,063.00 Cr..
- For Other Assets, as of Sep 2025, the value is 69,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 65,523.00 Cr. (Mar 2025) to 69,223.00 Cr., marking an increase of 3,700.00 Cr..
- For Total Assets, as of Sep 2025, the value is 85,310.00 Cr.. The value appears strong and on an upward trend. It has increased from 81,546.00 Cr. (Mar 2025) to 85,310.00 Cr., marking an increase of 3,764.00 Cr..
However, the Borrowings (54,513.00 Cr.) are higher than the Reserves (11,996.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 414.00 | -8.00 | -9.00 | -10.00 | -11.00 | -15.00 | -19.00 | -22.00 | -22.00 | -26.00 | -33.00 | -40.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 31 | 25 | 20 | 14 | 30 | 25 | 57 | 45 | 37 | 35 | 29 |
| Inventory Days | 69 | 58 | 50 | 73 | 42 | 52 | 42 | 76 | 53 | 44 | 50 | 49 |
| Days Payable | 116 | 108 | 71 | 85 | 96 | 88 | 90 | 162 | 150 | 96 | 85 | 99 |
| Cash Conversion Cycle | -5 | -19 | 5 | 8 | -39 | -6 | -22 | -30 | -52 | -16 | -0 | -21 |
| Working Capital Days | -45 | -41 | -23 | -21 | -54 | -13 | -31 | -44 | -52 | -34 | -50 | -37 |
| ROCE % | 8% | 17% | 15% | 17% | 16% | 9% | 5% | 6% | 11% | 15% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Large & Midcap Fund | 53,940,000 | 2.3 | 852.9 | 54,000,000 | 2025-12-15 07:28:09 | -0.11% |
| Nippon India Growth Mid Cap Fund | 51,844,304 | 1.95 | 819.76 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 41,080,000 | 2.17 | 649.56 | 39,000,000 | 2025-12-15 07:28:09 | 5.33% |
| HSBC Midcap Fund | 29,124,300 | 3.67 | 460.51 | N/A | N/A | N/A |
| SBI Flexicap Fund | 23,500,000 | 1.58 | 371.58 | N/A | N/A | N/A |
| HDFC Flexi Cap Fund | 20,500,000 | 0.34 | 324.15 | N/A | N/A | N/A |
| Franklin India Flexi Cap Fund | 17,710,254 | 1.4 | 280.03 | N/A | N/A | N/A |
| Kotak Multicap Fund | 16,515,000 | 1.17 | 261.14 | 17,835,000 | 2025-12-15 07:28:09 | -7.4% |
| Franklin India Focused Equity Fund | 14,300,000 | 1.76 | 226.11 | N/A | N/A | N/A |
| Axis Midcap Fund | 13,299,386 | 0.65 | 210.29 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| Diluted EPS (Rs.) | 10.56 | 8.45 | 4.22 | -1.22 | -0.56 |
| Cash EPS (Rs.) | 15.11 | 12.29 | 7.67 | 1.95 | 2.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Revenue From Operations / Share (Rs.) | 165.28 | 155.95 | 141.93 | 89.38 | 66.27 |
| PBDIT / Share (Rs.) | 32.58 | 27.53 | 17.72 | 9.72 | 8.84 |
| PBIT / Share (Rs.) | 28.88 | 24.37 | 14.66 | 6.77 | 5.99 |
| PBT / Share (Rs.) | 15.54 | 13.93 | 7.69 | -0.70 | -0.22 |
| Net Profit / Share (Rs.) | 11.41 | 9.13 | 4.60 | -0.99 | -0.23 |
| NP After MI And SOA / Share (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| PBDIT Margin (%) | 19.70 | 17.65 | 12.48 | 10.87 | 13.33 |
| PBIT Margin (%) | 17.47 | 15.62 | 10.32 | 7.56 | 9.03 |
| PBT Margin (%) | 9.40 | 8.93 | 5.41 | -0.78 | -0.34 |
| Net Profit Margin (%) | 6.90 | 5.85 | 3.24 | -1.11 | -0.35 |
| NP After MI And SOA Margin (%) | 6.40 | 5.42 | 2.97 | -1.36 | -0.84 |
| Return on Networth / Equity (%) | 25.39 | 27.58 | 14.50 | -4.90 | -2.10 |
| Return on Capital Employeed (%) | 15.37 | 17.46 | 13.33 | 7.94 | 6.80 |
| Return On Assets (%) | 3.80 | 3.67 | 2.26 | -0.82 | -0.39 |
| Long Term Debt / Equity (X) | 2.97 | 2.96 | 2.28 | 2.09 | 1.98 |
| Total Debt / Equity (X) | 4.06 | 4.51 | 3.61 | 3.28 | 2.31 |
| Asset Turnover Ratio (%) | 0.64 | 0.74 | 0.84 | 0.69 | 0.54 |
| Current Ratio (X) | 1.29 | 1.09 | 1.08 | 0.99 | 0.98 |
| Quick Ratio (X) | 1.14 | 0.94 | 0.92 | 0.86 | 0.82 |
| Inventory Turnover Ratio (X) | 12.14 | 7.58 | 9.45 | 6.96 | 6.04 |
| Dividend Payout Ratio (NP) (%) | 18.90 | 89.26 | 23.65 | -49.11 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.00 | 64.99 | 13.71 | 34.71 | 0.00 |
| Earning Retention Ratio (%) | 81.10 | 10.74 | 76.35 | 149.11 | 0.00 |
| Cash Earning Retention Ratio (%) | 86.00 | 35.01 | 86.29 | 65.29 | 0.00 |
| Interest Coverage Ratio (X) | 2.43 | 2.71 | 2.49 | 1.53 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.85 | 1.93 | 1.62 | 1.02 | 0.92 |
| Enterprise Value (Cr.) | 106013.76 | 86549.03 | 71834.36 | 57544.92 | 50957.36 |
| EV / Net Operating Revenue (X) | 2.18 | 1.89 | 1.72 | 2.19 | 2.62 |
| EV / EBITDA (X) | 11.08 | 10.71 | 13.80 | 20.18 | 19.65 |
| MarketCap / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| Retention Ratios (%) | 81.09 | 10.73 | 76.34 | 149.11 | 0.00 |
| Price / BV (X) | 4.90 | 5.58 | 4.78 | 4.71 | 4.24 |
| Price / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| EarningsYield | 0.05 | 0.04 | 0.03 | -0.01 | 0.00 |
After reviewing the key financial ratios for Ashok Leyland Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.56. This value is within the healthy range. It has increased from 8.45 (Mar 24) to 10.56, marking an increase of 2.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.11. This value is within the healthy range. It has increased from 12.29 (Mar 24) to 15.11, marking an increase of 2.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.28. It has increased from 155.95 (Mar 24) to 165.28, marking an increase of 9.33.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.58. This value is within the healthy range. It has increased from 27.53 (Mar 24) to 32.58, marking an increase of 5.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.88. This value is within the healthy range. It has increased from 24.37 (Mar 24) to 28.88, marking an increase of 4.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.54. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 15.54, marking an increase of 1.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 11.41, marking an increase of 2.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For PBDIT Margin (%), as of Mar 25, the value is 19.70. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 19.70, marking an increase of 2.05.
- For PBIT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 15.62 (Mar 24) to 17.47, marking an increase of 1.85.
- For PBT Margin (%), as of Mar 25, the value is 9.40. This value is below the healthy minimum of 10. It has increased from 8.93 (Mar 24) to 9.40, marking an increase of 0.47.
- For Net Profit Margin (%), as of Mar 25, the value is 6.90. This value is within the healthy range. It has increased from 5.85 (Mar 24) to 6.90, marking an increase of 1.05.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.40. This value is below the healthy minimum of 8. It has increased from 5.42 (Mar 24) to 6.40, marking an increase of 0.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.39. This value is within the healthy range. It has decreased from 27.58 (Mar 24) to 25.39, marking a decrease of 2.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.37. This value is within the healthy range. It has decreased from 17.46 (Mar 24) to 15.37, marking a decrease of 2.09.
- For Return On Assets (%), as of Mar 25, the value is 3.80. This value is below the healthy minimum of 5. It has increased from 3.67 (Mar 24) to 3.80, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 2.97. This value exceeds the healthy maximum of 1. It has increased from 2.96 (Mar 24) to 2.97, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 4.06. This value exceeds the healthy maximum of 1. It has decreased from 4.51 (Mar 24) to 4.06, marking a decrease of 0.45.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.74 (Mar 24) to 0.64, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 1.5. It has increased from 1.09 (Mar 24) to 1.29, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 1.14, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.14. This value exceeds the healthy maximum of 8. It has increased from 7.58 (Mar 24) to 12.14, marking an increase of 4.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.90. This value is below the healthy minimum of 20. It has decreased from 89.26 (Mar 24) to 18.90, marking a decrease of 70.36.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.00. This value is below the healthy minimum of 20. It has decreased from 64.99 (Mar 24) to 14.00, marking a decrease of 50.99.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.10. This value exceeds the healthy maximum of 70. It has increased from 10.74 (Mar 24) to 81.10, marking an increase of 70.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.00. This value exceeds the healthy maximum of 70. It has increased from 35.01 (Mar 24) to 86.00, marking an increase of 50.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.71 (Mar 24) to 2.43, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 3. It has decreased from 1.93 (Mar 24) to 1.85, marking a decrease of 0.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 106,013.76. It has increased from 86,549.03 (Mar 24) to 106,013.76, marking an increase of 19,464.73.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.18, marking an increase of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 11.08. This value is within the healthy range. It has increased from 10.71 (Mar 24) to 11.08, marking an increase of 0.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For Retention Ratios (%), as of Mar 25, the value is 81.09. This value exceeds the healthy maximum of 70. It has increased from 10.73 (Mar 24) to 81.09, marking an increase of 70.36.
- For Price / BV (X), as of Mar 25, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.58 (Mar 24) to 4.90, marking a decrease of 0.68.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ashok Leyland Ltd:
- Net Profit Margin: 6.9%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.37% (Industry Average ROCE: 22.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.39% (Industry Average ROE: 25.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.14
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33.9 (Industry average Stock P/E: 32.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 4.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.9%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto - LCVs/HCVs | No.1, Sardar Patel Road, Guindy, Chennai (Madras) Tamil Nadu 600032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dheeraj G Hinduja | Executive Chairman |
| Mr. Shenu Agarwal | Managing Director & CEO |
| Mr. Shom Ashok Hinduja | Director |
| Ms. Sanjay K Asher | Director |
| Mr. Manisha Girotra | Director |
| Mr. Gopal Mahadevan | Director |
| Mr. Jose Maria Alapont | Director |
| Mr. Saugata Gupta | Director |
| Dr. C Bhaktavatsala Rao | Director |
| Dr. V Sumantran | Director |
| Mr. Thomas Dauner | Director |
| Mr. Sven Christoph Ennerst | Director |
FAQ
What is the intrinsic value of Ashok Leyland Ltd?
Ashok Leyland Ltd's intrinsic value (as of 23 January 2026) is ₹251.80 which is 30.47% higher the current market price of ₹193.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,13,252 Cr. market cap, FY2025-2026 high/low of ₹199/95.2, reserves of ₹11,996 Cr, and liabilities of ₹85,310 Cr.
What is the Market Cap of Ashok Leyland Ltd?
The Market Cap of Ashok Leyland Ltd is 1,13,252 Cr..
What is the current Stock Price of Ashok Leyland Ltd as on 23 January 2026?
The current stock price of Ashok Leyland Ltd as on 23 January 2026 is ₹193.
What is the High / Low of Ashok Leyland Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ashok Leyland Ltd stocks is ₹199/95.2.
What is the Stock P/E of Ashok Leyland Ltd?
The Stock P/E of Ashok Leyland Ltd is 33.9.
What is the Book Value of Ashok Leyland Ltd?
The Book Value of Ashok Leyland Ltd is 21.4.
What is the Dividend Yield of Ashok Leyland Ltd?
The Dividend Yield of Ashok Leyland Ltd is 1.62 %.
What is the ROCE of Ashok Leyland Ltd?
The ROCE of Ashok Leyland Ltd is 14.3 %.
What is the ROE of Ashok Leyland Ltd?
The ROE of Ashok Leyland Ltd is 28.8 %.
What is the Face Value of Ashok Leyland Ltd?
The Face Value of Ashok Leyland Ltd is 1.00.